AstraZeneca's dynamic duo wants to dominate in cancer drugs - STAT -ohzschool

  1. AstraZeneca's dynamic duo wants to dominate in cancer drugs  STAT
  2. Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation  CNN
  3. ASCO: AZ, Merck's Lynparza fends off pancreatic cancer, cutting progression risk in half  FiercePharma
  4. New drug therapy slows spread of pancreatic cancer: study  St. Lucia News Online
  5. Lynparza stalls pancreatic cancer in patients with BRCA mutations: study  CNA
  6. View full coverage on Google News


Next Post Previous Post
No Comment
Add Comment
comment url